المؤلفون: D. A. Granov, I. I. Tileubergenov, A. R. Sheraliev, V. N. Zhuikov, A. A. Polikarpov, A. V. Moiseenko, Д. А. Гранов, И. И. Тилеубергенов, А. Р. Шералиев, В. Н. Жуйков, А. А. Поликарпов, А. В. Моисеенко

المساهمون: Работа выполнена в рамках государственного задания Министерства здравоохранения Российской Федерации (тема № 121040200134-6)

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 26, № 1 (2024); 8-19 ; Вестник трансплантологии и искусственных органов; Том 26, № 1 (2024); 8-19 ; 2412-6160 ; 1995-1191

مصطلحات موضوعية: регионарная химиотерапия, hilar cholangiocarcinoma, liver transplantation, photodynamic therapy, regional chemotherapy, гилюсная холангиокарцинома, трансплантация печени, фотодинамическая терапия

وصف الملف: application/pdf

العلاقة: https://journal.transpl.ru/vtio/article/view/1730/1558Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1493Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1498Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1499Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1500Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1501Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1502Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1503Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1504Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1505Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1506Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1507Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1508Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1509Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1730/1510Test; Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014 Feb; 3 (1): 18–34. doi:10.3978/j.issn.2304-3881.2014.02.05. PMID: 24696835; PMCID: PMC3955000.; Molina V, Sampson J, Ferrer J, Sanchez-Cabus S, Calatayud D, Pavel MC et al. Klatskin Tumor: Diagnosis, Preoperative Evaluation and Surgical Considerations. Cir Esp. 2015 Nov; 93 (9): 552–60. ISSN 2173-5077. https://doi.org/10.1016/j.cireng.2015.07.002Test.; Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y. Evolution of surgical treatmentfor perihilar cholangiocarcinoma: a single-center 34year review of 574 consecutive resections. Ann Surg. 2013 Jul; 258 (1): 129–140.; Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001 Oct; 234 (4): 507–517; discussion 517-9.; Groot Koerkamp B, Wiggers JK, Allen PJ, Besselink MG, Blumgart LH, Busch OR et al. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. J Am Coll Surg. 2015 Dec; 221 (6): 1041–1049. ISSN 1072-7515. https://doi.org/10.1016/j.jamcollsurg.2015.09.005Test.; Руммо ОО, Щерба АЕ, Авдей ЕЛ, Федорук АМ, Дзядзько АМ, Ефимов ДЮ. Оценка эффективности различных способов хирургического лечения опухолей ворот печени. Анналы хирургической гепатологии. 2013; 18 (2): 43–49.; Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB et al. Transplantation for hilar cholangiocarcinoma. Liver Transpl. 2004 Oct; 10 (10 Suppl 2): S65–S68. doi:10.1002/lt.20266. PMID:15382214.; Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM et al. SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015 Aug 20; 33 (24): 2617–2622.; Turgeon MK, Maithel SK. Cholangiocarcinoma: a sitespecific update on the current state of surgical management and multi-modality therapy. Chin Clin Oncol. 2020 Feb; 9 (1): 4.; Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H et al. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg. 2009 Aug; 13 (8): 1470–1479.; Robles R, Figueras J, Turrión VS, Margarit C, Moya A, Varo E et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004 Feb; 239 (2): 265–271. doi:10.1097/01.sla.0000108702.45715.81. PMID: 14745336; PMCID:PMC1356221.; Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int. 2010 Jul; 23 (7): 692–697. doi:10.1111/j.1432-2277.2010.01108.x. Epub 2010 May 20. PMID: 20497401.; Foo ML, Gunderson LL, Bender CE, Buskirk SJ. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1997 Nov 1; 39 (4): 929–935. doi:10.1016/s0360-3016(97)00299-x. PMID: 9369143.; JarnaginWR,RuoL,Little SA,KlimstraD,D’Angelica M, DeMatteo RP et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003 Oct 15; 98 (8): 1689–1700. doi:10.1002/cncr.11699. PMID: 14534886.; Гранов ДА, Шаповал СВ, Гапбаров АЧ, Моисеенко АВ. Комбинация методов регионарной терапии в лечении неоперабельной опухоли Клатскина. Высокотехнологическая медицина. 2020; 4: 8–16.; Гранов ДА, Поликарпов АА, Таразов ПГ, Тимергалин ИВ, Полысалов ВН. Опухоль Клатскина, осложненная механической желтухой и холангитом, в реальной практике: нерезектабельная опухоль или инкурабельный пациент? Вестник хирургии имени И.И. Грекова. 2020; 179 (4): 9–16. https://doi.org/10.24884/0042-4625-2020-179-4-9-16Test.; Benson AB, D’Angelica MI, Abbott DE, Anaya DA, Anders R, Are C et al. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021; 19 (5): 541–565. doi:10.6004/jnccn.2021.0022.; Бредер ВВ, Базин ИС, Косырев ВЮ, Ледин ЕВ. Практические рекомендации по лекарственному лечению билиарного рака. Злокачественные опухоли. 2021; 10 (3s2-1): 470–486. doi:10.18027/2224-5057-2020-10-3s2-26.; Бредер ВВ. Рак желчевыводящей системы. Практическая онкология. 2012; 13 (4): 269–275.; Polistina FA, Guglielmi R, Baiocchi C, Francescon P, Scalchi P, Febbraro A et al. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiother Oncol. 2011 May; 99 (2): 120–123. ISSN 01678140. https://doi.org/10.1016/j.radonc.2011.05.016Test.; Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003 Nov; 125 (5): 1355–1363. doi:10.1016/j.gastro.2003.07.015. PMID:14598251.; Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol. 2005 Nov; 100 (11): 2426–2430. doi:10.1111/j.15720241.2005.00318.x. PMID: 16279895.; Lee TY, Cheon YK, Shim CS, Cho YD. Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma. World J Gastroenterol. 2012 Oct 21; 18 (39): 5589–5594. doi:10.3748/wjg.v18.i39.5589. PMID: 23112552; PMCID:PMC3482646.; Wagner A, Kiesslich T, Neureiter D, Friesenbichler P, Puespoek A, Denzer UW et al. Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin. Photochem Photobiol Sci. 2013 Jun; 12 (6): 1065–1073. doi:10.1039/c3pp25425a. Epub 2013 Apr 4. PMID:23558738.; Долгушин БИ, Сергеева ОН, Францев ДЮ, Кукушкин АВ, ПановВО,ВиршкеЭРи др. Внутрипротоковая фотодинамическая терапия при воротной холангиокарциноме у неоперабельных больных. Анналы хирургической гепатологии. 2016; 21 (3): 106–118. https://doi.org/10.16931/1995-5464.20163106-118Test.; Zhang C, Song M, Sun Z, Fang Y, Liu Y, Xu K et al. Biliary drainage combined with simultaneous 125I seed strand brachytherapy for the treatment of hilar cholangiocarcinoma. BMC Cancer. 2023 May 9; 23 (1): 418. https://doi.org/10.1186/s12885-023-10868-5Test.; Ito T, Butler JR, Noguchi D, Ha M, Aziz A, Agopian VG et al. A 3-Decade, Single-Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy. Liver Transpl. 2022 Mar; 28 (3): 386–396. doi:10.1002/lt.26285. Epub 2021 Oct 21. PMID: 34482610.; https://journal.transpl.ru/vtio/article/view/1730Test

الإتاحة: https://doi.org/10.15825/1995-1191-2024-1-8-19Test
https://doi.org/10.3978/j.issn.2304-3881.2014.02.05Test
https://doi.org/10.1016/j.cireng.2015.07.002Test
https://doi.org/10.1016/j.jamcollsurg.2015.09.005Test
https://doi.org/10.1002/lt.20266Test
https://doi.org/10.1097/01.sla.0000108702.45715.81Test
https://doi.org/10.1111/j.1432-2277.2010.01108.xTest
https://doi.org/10.1016/s0360-3016Test(97)00299-x
https://doi.org/10.1002/cncr.11699Test
https://doi.org/10.6004/jnccn.2021.0022Test

المؤلفون: D. A. Granov, V. N. Zhuikov, I. I. Tileubergenov, I. O. Rutkin, A. A. Polikarpov, A. R. Sheraliev, M. V. Rozdobara, Д. А. Гранов, В. Н. Жуйков, И. И. Тилеубергенов, И. О. Руткин, А. А. Поликарпов, А. Р. Шералиев, М. В. Роздобара

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 25, № 4 (2023); 8-16 ; Вестник трансплантологии и искусственных органов; Том 25, № 4 (2023); 8-16 ; 2412-6160 ; 1995-1191

مصطلحات موضوعية: Associated Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS), liver transplantation, Milan criteria, transplant hepatectomy, трансплантация печени, Миланские критерии, резекция трансплантата печени

وصف الملف: application/pdf

العلاقة: https://journal.transpl.ru/vtio/article/view/1692/1535Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1692/1435Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1692/1437Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1692/1438Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1692/1439Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1692/1440Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1692/1441Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1692/1442Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1692/1443Test; Kardashian A, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, et al. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology. 2020 Dec;72(6):2014-2028. doi:10.1002/hep.31210. PMID: 32124453.; Ince V, Sahin TT, Akbulut S, Yilmaz S. Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria. World J Clin Cases. 2022 Oct 16;10(29):10413-10427. doi:10.12998/wjcc.v10.i29.10413. PMID: 36312504; PMCID: PMC9602233.; Hoffman D, Mehta N. Recurrence of hepatocellular carcinoma following liver transplantation. Expert Rev Gastroenterol Hepatol. 2021 Jan;15(1):91-102. doi:10.1080/17474124.2021.1823213. Epub 2020 Sep 23. PMID: 32933351.; Sapisochin G, Goldaracena N, Astete S, Laurence JM, Davidson D, Rafael E, et al. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series. Ann Surg Oncol. 2015 Jul;22(7):2286-94. doi:10.1245/s10434-014-4273-6. Epub 2014 Dec 4. PMID: 25472651.; Kornberg A, Küpper B, Tannapfel A, Katenkamp K, Thrum K, Habrecht O, et al. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables. Eur J Surg Oncol. 2010 Mar;36(3):275-80. doi:10.1016/j.ejso.2009.10.001. Epub 2009 Oct 25. PMID: 19857941.; Bodzin AS, Lunsford KE, Markovic D, Harlander-Locke MP, Busuttil RW, Agopian VG. Predicting Mortality in Patients Developing Recurrent Hepatocellular Carcinoma After Liver Transplantation: Impact of Treatment Modality and Recurrence Characteristics. Ann Surg. 2017 Jul;266(1):118-125. doi:10.1097/SLA.0000000000001894. PMID: 27433914.; Pelizzaro F, Gambato M, Gringeri E, Vitale A, Cillo U, Farinati F, et al. Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers (Basel). 2021 Sep 29;13(19):4882. doi:10.3390/cancers13194882. PMID: 34638365; PMCID: PMC8508053.; Filgueira NA. Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation. World J Hepatol. 2019 Mar 27;11(3):261-272. doi:10.4254/wjh.v11.i3.261. PMID: 30967904; PMCID: PMC6447422.; Zhai H, Liang P, Yu XL, Cheng Z, Han ZY, Liu F, et al. Microwave ablation in treating intrahepatic recurrence of hepatocellular carcinoma after liver transplantation: An analysis of 11 cases. Int J Hyperthermia. 2015;31(8):863-8. doi:10.3109/02656736.2015.1091953. Epub 2015 Nov 25. PMID: 26608701.; Ko HK, Ko GY, Yoon HK, Sung KB. Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation. Korean J Radiol. 2007 Jul-Aug;8(4):320-7. doi:10.3348/kjr.2007.8.4.320. PMID: 17673843; PMCID: PMC2627154.; Iavarone M, Invernizzi F, Ivanics T, Mazza S, Zavaglia C, Sanduzzi-Zamparelli M, et al. Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study. Liver Transpl. 2021 Dec;27(12):1767-1778. doi:10.1002/lt.26264. Epub 2021 Sep 16. PMID: 34388851.; Kittai AS, Oldham H, Cetnar J, Taylor M. Immune Checkpoint Inhibitors in Organ Transplant Patients. J Immunother. 2017 Sep;40(7):277-281. doi:10.1097/CJI.0000000000000180. PMID: 28719552.; Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020 May 14;382(20):1894-1905. doi:10.1056/NEJMoa1915745. PMID: 32402160.; Rimassa L, Personeni N, Czauderna C, Foerster F, Galle P. Systemic treatment of HCC in special populations. J Hepatol. 2021 Apr;74(4):931-943. doi:10.1016/j.jhep.2020.11.026. Epub 2020 Nov 26. PMID: 33248171.; Regalia E, Fassati LR, Valente U, Pulvirenti A, Damilano I, Dardano G, et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg. 1998;5(1):29-34. doi:10.1007/pl00009947. PMID: 9683751.; Pohl JMO, Raschzok N, Eurich D, Pflüger M, Wiering L, Daneshgar A, et al. Outcomes of Liver Resections after Liver Transplantation at a High-Volume Hepatobiliary Center. J Clin Med. 2020 Nov 17;9(11):3685. doi:10.3390/jcm9113685. PMID: 33212913; PMCID: PMC7698397.; Asencio JM, García Sabrido JL, Olmedilla L. How to expand the safe limits in hepatic resections? J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):399-404. doi:10.1002/jhbp.97. Epub 2014 Feb 13. PMID: 24532454.; https://journal.transpl.ru/vtio/article/view/1692Test

الإتاحة: https://doi.org/10.15825/1995-1191-2023-4-8-16Test
https://doi.org/10.1002/hep.31210Test
https://doi.org/10.12998/wjcc.v10.i29.10413Test
https://doi.org/10.1080/17474124.2021.1823213Test
https://doi.org/10.1245/s10434-014-4273-6Test
https://doi.org/10.1016/j.ejso.2009.10.001Test
https://doi.org/10.1097/SLA.0000000000001894Test
https://doi.org/10.3390/cancers13194882Test
https://doi.org/10.4254/wjh.v11.i3.261Test
https://doi.org/10.3109/02656736.2015.1091953Test

المؤلفون: A. N. Polyakov, D. A. Granov, Yu. I. Patyutko, I. A. Pokataev, A. A. Polikarpov, T. I. Kagacheva, I. S. Bazin, A. Sh. Umirzokov, D. Yu. Frantsev, V. N. Zhuikov, D. V. Podluzhny, А. Н. Поляков, Д. А. Гранов, Ю. И. Патютко, И. A. Покатаев, А. А. Поликарпов, Т. И. Кагачева, И. С. Базин, А. Ш. Умирзоков, Д. Ю. Францев, В. Н. Жуйков, Д. В. Подлужный

المصدر: Research and Practical Medicine Journal; Том 10, № 1 (2023); 57-67 ; Research'n Practical Medicine Journal; Том 10, № 1 (2023); 57-67 ; 2410-1893 ; 10.17709/2410-1893-2023-10-1

مصطلحات موضوعية: факторы неблагоприятного прогноза, combination therapy, preoperative chemotherapy, transarterial chemoembolization, hepatic artery infusion chemotherapy, post‑resection liver failure, poor prognostic factors, комбинированное лечение, предоперационная химиотерапия, химиоэмболизация печеночной артерии, химиоинфузия печеночной артерии, пострезекционная печеночная недостаточность

وصف الملف: application/pdf

العلاقة: https://www.rpmj.ru/rpmj/article/view/860/538Test; https://www.rpmj.ru/rpmj/article/view/860/546Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/707Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/708Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/709Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/710Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/711Test; Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, et al.; BILCAP study group. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019 May;20(5):663–673. https://doi.org/10.1016/s1470Test‑2045(18)30915‑x Erratum in: Lancet Oncol. 2019 Apr 2.; Yadav S, Xie H, Bin‑Riaz I, Sharma P, Durani U, Goyal G, et al. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: propensity score matched analysis. Eur J Surg Oncol. 2019 Aug;45(8):1432–1438. https://doi.org/10.1016/j.ejso.2019.03.023Test; Tsilimigras DI, Sahara K, Wu L, Moris D, Bagante F, Guglielmi A, et al. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches. JAMA Surg. 2020 Sep 1;155(9):823–831. https://doi.org/10.1001/jamasurg.2020.1973Test; Rizzo A, Brandi G. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Cancer Treat Res Commun. 2021;27:100354. https://doi.org/10.1016/j.ctarc.2021.100354Test; Zhang XF, Beal EW, Bagante F, Chakedis J, Weiss M, Popescu I, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg. 2018 Jun;105(7):848–856. https://doi.org/10.1002/bjs.10676Test; Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al.; ABC‑02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010 Apr 8;362(14):1273–1281. https://doi.org/10.1056/nejmoa0908721Test; Rizzo A, Brandi G. First‑line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC‑02 Trial: “And Yet It Moves!”. Cancer Treat Res Commun. 2021;27:100335. https://doi.org/10.1016/j.ctarc.2021.100335Test; Cho Y, Kim TH, Seong J. Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma. Strahlenther Onkol. 2017 Aug;193(8):620–629. https://doi.org/10.1007/s00066Test‑017‑1128‑7; Kato A, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, et al. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single‑center study. Ann Surg Oncol. 2013 Jan;20(1):318–324. https://doi.org/10.1245/s10434Test‑012‑2312‑8; Shroff RT, Javle MM, Xiao L, Kaseb AO, Varadhachary GR, Wolff RA, et al. Gemcitabine, Cisplatin, and nab‑Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial. JAMA Oncol. 2019 Jun 1;5(6):824–830. https://doi.org/10.1001/jamaoncol.2019.0270Test; Ray CE Jr, Edwards A, Smith MT, Leong S, Kondo K, Gipson M, et al. Metaanalysis of survival, complications, and imaging response following chemotherapy‑based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma. J Vasc Interv Radiol. 2013 Aug;24(8):1218–1226. https://doi.org/10.1016/j.jvir.2013.03.019Test; Holster JJ, El Hassnaoui M, Franssen S, IJzermans JNM, de Jonge J, Mostert B, et al. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta‑Analysis. Ann Surg Oncol. 2022 Sep;29(9):5528–5538. https://doi.org/10.1245/s10434Test‑022‑11439‑x; https://www.rpmj.ru/rpmj/article/view/860Test

الإتاحة: https://doi.org/10.17709/2410-1893-2023-10-1-5Test
https://doi.org/10.17709/2410-1893-2023-10-1Test
https://doi.org/10.1016/s1470Test‑2045(18)30915‑x
https://doi.org/10.1016/j.ejso.2019.03.023Test
https://doi.org/10.1001/jamasurg.2020.1973Test
https://doi.org/10.1016/j.ctarc.2021.100354Test
https://doi.org/10.1002/bjs.10676Test
https://doi.org/10.1056/nejmoa0908721Test
https://doi.org/10.1016/j.ctarc.2021.100335Test
https://doi.org/10.1007/s00066Test‑017‑1128‑7

المؤلفون: V. V. Borovik, A. A. Polikarpov, D. A. Granov, В. В. Боровик, А. А. Поликарпов, Д. А. Гранов

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 24, № 3 (2022); 32-36 ; Вестник трансплантологии и искусственных органов; Том 24, № 3 (2022); 32-36 ; 2412-6160 ; 1995-1191

مصطلحات موضوعية: ранние артериальные осложнения, neoadjuvant chemoembolization, early arterial complications, неоадъювантная химиоэмболизация

وصف الملف: application/pdf

العلاقة: https://journal.transpl.ru/vtio/article/view/1486/1327Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1486/1029Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1486/1059Test; Li H, Li B, Wei Y, Yan L, Wen T, Wang W et al. Preoperative transarterial chemoembolization does not increase hepatic artery complications after liver transplantation: A single center 12-year experience. Clin Res Hepatol Gastroenterol. 2015 Sep; 39 (4): 451–457.; Gilbo N, Van Praet L, Jochmans I, Sainz-Barriga M, Verslype C, Maleux G et al. Pre-operative trans-catheter arterial chemo-embolization increases hepatic artery thrombosis after liver transplantation – a retrospective study. Transpl Int. 2018 Jan; 31 (1): 71–81.; Sneiders D, Houwen T, Pengel LHM, Polak WG, Dor FJMF, Hartog H. Systematic Review and MetaAnalysis of Posttransplant Hepatic Artery and Biliary Complications in Patients Treated With Transarterial Chemoembolization Before Liver Transplantation. Transplantation. 2018 Jan; 102 (1): 88–96.; Ogawa K, Takada Y. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation. Cancers (Basel). 2022 Jan 13; 14 (2): 396.; Panaro F, Ramos J, Gallix B, Mercier G, Herrero A, Niampa H et al. Hepatic artery complications following liver transplantation. Does preoperative chemoembolization impact the postoperative course? HAL. Id: hal-03562828. https://hal.archives-ouvertes.fr/hal03562828Test. Submitted on 9 Feb 2022.; Полехин АС, Таразов ПГ, Поликарпов АА, Гранов ДА. Химиоэмболизация печеночной артерии в лечении больных гепатоцеллюлярным раком на фоне выраженного цирроза печени. Вестник хирургии имени И.И. Грекова. 2019; 178 (6): 29–35.; Поликарпов АА. Рентгеноэндоваскулярные вмешательства в лечении нерезектабельных злокачественных опухолей печени: автореф. дис. … д-ра мед. наук. Санкт-Петербург, 2006. 42 с.; Гранов ДА, Полехин АС, Таразов ПГ, Руткин ИО, Тилеубергенов ИИ, Боровик ВВ. Химиоэмболизация печеночных артерий у больных гепатоцеллюлярным раком на фоне цирроза перед трансплантацией печени: прогностическое значение концентрации альфафетопротеина. Вестник трансплантологии и искусственных органов. 2020; 22 (4): 52–57.; Моисеенко АВ, Поликарпов АА, Таразов ПГ, Тилеубергенов ИИ, Майстренко ДН, Гранов ДА. Рентгенэндоваскулярные вмешательства в коррекции артериальных осложнений после ортотопической трансплантации печени. Диагностическая и интервенционная радиология. 2021; 15 (1): 51–58.; https://journal.transpl.ru/vtio/article/view/1486Test

الإتاحة: https://doi.org/10.15825/1995-1191-2022-3-32-36Test
https://journal.transpl.ru/vtio/article/view/1486Test

المؤلفون: D. A. Granov, I. I. Tileubergenov, V. N. Zhuikov, A. R. Sheraliev, A. A. Polikarpov, A. V. Moiseenko, Д. А. Гранов, И. И. Тилеубергенов, В. Н. Жуйков, А. Р. Шералиев, А. А. Поликарпов, А. В. Моисеенко

المساهمون: Работа выполнена в рамках государственного задания Министерства здравоохранения Российской Федерации (тема №121040200134-6)

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 24, № 1 (2022); 7-14 ; Вестник трансплантологии и искусственных органов; Том 24, № 1 (2022); 7-14 ; 2412-6160 ; 1995-1191

مصطلحات موضوعية: регионарная химиотерапия, hilar cholangiocarcinoma, liver transplantation, photodynamic therapy, regional chemotherapy, гилюсная холангиокарцинома, трансплантация печени, фотодинамическая терапия

وصف الملف: application/pdf

العلاقة: https://journal.transpl.ru/vtio/article/view/1447/1264Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1447/985Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1447/986Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1447/987Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1447/988Test; https://journal.transpl.ru/vtio/article/downloadSuppFile/1447/989Test; Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014 Feb; 3 (1): 18–34. doi:10.3978/j. issn.2304-3881.2014.02.05. PMID: 24696835; PMCID: PMC3955000.; Molina V, Sampson J, Ferrer J, Sanchez-Cabus S, Calatayud D, Pavel MC et al. Klatskin Tumor: Diagnosis, Preoperative Evaluation and Surgical Considerations. Cirugía Española (English Edition). 2015; 93 (9): 552–560. ISSN 2173-5077. https://doi.org/10.1016/j.cireng.2015.07.002Test.; Groot Koerkamp B, Wiggers JK, Allen PJ, Besselink MG, Blumgart LH, Busch OR et al. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. Journal of the American College of Surgeons. 2015; 221 (6): 1041–1049. ISSN 1072-7515. https://doi.org/10.1016/j.jamcollsurg.2015.09.005Test.; Руммо ОО, Щерба АЕ, Авдей ЕЛ, Федорук АМ, Дзядзько АМ, Ефимов ДЮ. Оценка эффективности различных способов хирургического лечения опухолей ворот печени. Анналы хирургической гепатологии. 2013; 18 (2): 43–49.; Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB et al. Transplantation for hilar cholangiocarcinoma. Liver Transpl. 2004 Oct; 10 (10 Suppl 2): S65–68. doi:10.1002/lt.20266. PMID: 15382214.; Robles R, Figueras J, Turrión VS, Margarit C, Moya A, Varo E et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004 Feb; 239 (2): 265–271. doi:10.1097/01. sla.0000108702.45715.81. PMID: 14745336; PMCID: PMC1356221.; Foo ML, Gunderson LL, Bender CE, Buskirk SJ. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1997 Nov 1; 39 (4): 929–935. doi:10.1016/s0360-3016(97)00299-x. PMID: 9369143.; JarnaginWR,RuoL,Little SA,KlimstraD,D’Angelica M, DeMatteo RP et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003 Oct 15; 98 (8): 1689–1700. doi:10.1002/cncr.11699. PMID: 14534886.; Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int. 2010 Jul; 23 (7): 692–697. doi:10.1111/j.1432-2277.2010.01108.x. Epub 2010 May 20. PMID: 20497401.; Гранов ДА, Шаповал СВ, Гапбаров АЧ, Моисеенко АВ. Комбинация методов регионарной терапии в лечении неоперабельной опухоли Клатскина. Высокотехнологическая медицина. 2020; 4: 8–16.; Гранов ДА, Поликарпов АА, Таразов ПГ, Тимергалин ИВ, Полысалов ВН. Опухоль Клатскина, осложненная механической желтухой и холангитом, в реальной практике: нерезектабельная опухоль или инкурабельный пациент? Вестник хирургии имени И.И. Грекова. 2020; 179 (4): 9–16. (4): 9–16. [In Russ, English abstract]. https://doiTest. org/10.24884/0042-4625-2020-179-4-9-16.; Benson AB, D’Angelica MI, Abbott DE, Anaya DA, Anders R, Are C et al. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021; 19 (5): 541–565. doi:10.6004/jnccn.2021.0022.; Бредер ВВ, Базин ИС, Косырев ВЮ, Ледин ЕВ. Практические рекомендации по лекарственному лечению билиарного рака. Злокачественные опухоли. 2021; 10 (3s2-1): 470–486.; Бредер ВВ. Рак желчевыводящей системы. Практическая онкология. 2012; 13 (4): 269–275.; Polistina FA, Guglielmi R, Baiocchi C, Francescon P, Scalchi P, Febbraro A et al. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiotherapy and Oncology. 2011; 99 (Issue 2): 120–123. ISSN 0167-8140. https://doi.org/10.1016/jTest. radonc.2011.05.016.; Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003 Nov; 125 (5): 1355–1363. doi:10.1016/j.gastro.2003.07.015. PMID: 14598251.; Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol. 2005 Nov; 100 (11): 2426–2430. doi:10.1111/j.1572- 0241.2005.00318.x. PMID: 16279895.; Lee TY, Cheon YK, Shim CS, Cho YD. Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma. World J Gastroenterol. 2012 Oct 21; 18 (39): 5589–5594. doi:10.3748/wjg.v18.i39.5589. PMID: 23112552; PMCID: PMC3482646.; Wagner A, Kiesslich T, Neureiter D, Friesenbichler P, Puespoek A, Denzer UW et al. Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin. Photochem Photobiol Sci. 2013 Jun; 12 (6): 1065–1073. doi:10.1039/c3pp25425a. Epub 2013 Apr 4. PMID: 23558738.; Ito T, Butler JR, Noguchi D, Ha M, Aziz A, Agopian VG et al. A 3-Decade, Single-Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy. Liver Transpl. 2021 Sep 5. doi:10.1002/lt.26285. Epub ahead of print. PMID: 34482610.; https://journal.transpl.ru/vtio/article/view/1447Test

الإتاحة: https://doi.org/10.15825/1995-1191-2022-1-7-14Test
https://doi.org/10.3978/jTest
https://doi.org/10.1016/j.cireng.2015.07.002Test
https://doi.org/10.1016/j.jamcollsurg.2015.09.005Test
https://doi.org/10.1002/lt.20266Test
https://doi.org/10.1097/01Test
https://doi.org/10.1016/s0360-3016Test(97)00299-x
https://doi.org/10.1002/cncr.11699Test
https://doi.org/10.1111/j.1432-2277.2010.01108.xTest
https://doi.org/10.6004/jnccn.2021.0022Test

المؤلفون: P. G. Tarazov, A. A. Polikarpov, D. A. Granov, V. V. Borovik, П. Г. Таразов, А. А. Поликарпов, Д. А. Гранов, В. В. Боровик

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 23, № 1 (2021); 38-42 ; Вестник трансплантологии и искусственных органов; Том 23, № 1 (2021); 38-42 ; 2412-6160 ; 1995-1191

مصطلحات موضوعية: беременность, biliary stricture, biliary stenting, broken stent, pregnancy, билиарная стриктура, стентирование желчных протоков, сломавшийся стент

وصف الملف: application/pdf

العلاقة: https://journal.transpl.ru/vtio/article/view/1313/1082Test; https://journal.transpl.ru/vtio/article/view/1313/1181Test; Shao H, Arellano RS. Percutaneous management of benign and postoperative biliary strictures. Digestive Disease Interventions. 2017; 1 (1): 28-35. doi:10.1055/s-0037-1599254.; Nemes B, Gaman G, Doros A. Biliary complications after liver transplantation. Expert Review of Gatroenterology and Hepatology. 2015; 9 (4): 447-466. doi: https://doi.org/10.1586/17474124.2015.967761Test.; Поликарпов АА, Таразов ПГ, Полехин АС и др. Билиарный манометрический тест в оценке эфективности баллонной пластики неанастомотических стриктур желчных протоков после ортотопической трансплантации печени. Современные технологии в медицине. 2017; 9 (4): 60-65. doi:10.17691/stm2017.9.4.07.; Deviere J, Reddy DN, Puspok A et al. Successful management of benign biliary strictures with fully covered self-expanding metal stents. Gastroenterology. 2014; 147 (2): 385-395. doi: https://doi.org./10.1053/j.gastro.2014.04.043Test.; Tarantino I, Barresi L, Curcio G et al. Definitive outcomes of self-expandable metal stents in patients with refractory post-transplant biliary anastomotic stenosis. Digestive and Liver Diseases. 2015; 47 (7): 562-565. doi: https://doi.org/10.1016/j.dld.2015.03.001Test.; Kawakubo K, Isayama H, Tsujino T et al. Endoscopic removal of a spontaneously fractured biliary uncovered self-expandable metal stent. Digestive Endoscopy. 2012; 24 (3); 182-184. doi: https://doi.org/10.1111/j.1443-1661.2011.01189.xTest.; Zuber-Jerger I, Kullmann F. Trimming of a broken migrated biliary metal stent with the Nd:YAG laser. Case Reports in Gastroenterology. 2009; 3 (1): 16-20. doi:10.1159/000206976.; Хатьков ИЕ, Аванесян РГ, Ахаладзе ГГ и др. Российский консенсус по актуальным вопросам диагностики и лечения синдрома механической желтухи. Хирургия. 2020; 6: 5-17. doi: https//doi.org/10.17116/hirurgia20200615.; Dopazo C, Diez I, Quintero J et al. Role of biodegradable stents as part of treatment of biliary strictures after pediatric and adult liver transplantation: an observational single-center study. Journal of Vascular and Interventional Radiology. 2018; 29 (6): 899-904. doi: https://doi.org/10.1016/j.jvir.2018.02.007Test.; Battistel M, Senzolo M, Ferrarese A et al. Biodegradable biliary stents for percutaneous treatment of post-liver transplantation refractory benign biliary anastomotic strictures. Cardiovascular and Interventional Radiology. 2020; 43 (5): 749-755. doi: https://doi.org/10.1007/s00270-020-02442-4Test.; https://journal.transpl.ru/vtio/article/view/1313Test

الإتاحة: https://doi.org/10.15825/1995-1191-2021-1-38-42Test
https://doi.org/10.1055/s-0037-1599254Test
https://doi.org/10.1586/17474124.2015.967761Test
https://doi.org/10.17691/stm2017.9.4.07Test
https://doi.org/10.1016/j.dld.2015.03.001Test
https://doi.org/10.1111/j.1443-1661.2011.01189.xTest
https://doi.org/10.1159/000206976Test
https://doi.org/10.17116/hirurgia20200615Test
https://doi.org/10.1016/j.jvir.2018.02.007Test
https://doi.org/10.1007/s00270-020-02442-4Test

المؤلفون: A. V. Moiseenko, A. A. Polikarpov, P. G. Tarazov, D. A. Granov, А. В. Моисеенко, А. А. Поликарпов, П. Г. Таразов, Д. А. Гранов

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 22, № 3 (2020); 99-106 ; Вестник трансплантологии и искусственных органов; Том 22, № 3 (2020); 99-106 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2020-3

مصطلحات موضوعية: перфузионная ангиография, blood flow, stenting, splenic artery embolization, graft perfusion angiography, кровоснабжение, стентирование, эмболизация селезеночной артерии

وصف الملف: application/pdf

العلاقة: https://journal.transpl.ru/vtio/article/view/1232/1005Test; https://journal.transpl.ru/vtio/article/view/1232/1028Test; Guan Y-S, Hu Y. Clinical application of partial splenic embolization. The Scientific World Journal. 2014; 1–9. doi:10.1155/2014/961345/.; Prieto M, Gastaca M, Valdivieso A et al. Does low hepatic artery flow increase rate of biliary strictures in deceased donor liver transplantation? Letter. The author’s reply Kim PT., Fernandez H., Gupta A. et al. Transplantation. 2017; 101 (2): 332–340. doi:10.1097/TP.0000000000001564.; Buis CI, Verdonk RC, Van der Jagt EJ et al. Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs late presentation. Liver Transplantation. 2007; 13: 708–718. doi:10.1002/lt.21166.; Seehofer D, Eurich D, Veltzke-Schlieker W et al. Biliary complications after liver transplantation: old problems and new challenges. American Journal of Transplantation. 2013; 13: 253–265. doi:10.1111/ajt.12034.; Goldsmith LE, Wiebke K, Seal J et al. Complications after endovascular treatment of hepatic artery stenosis after liver transplantation. Journal of Vascular Surgery. 2017; 66 (5): 1488–1496. doi:10.1016/j.jvs.2017.04.062.; Dariushnia SR, Gill AE, Martin LG et al. Quality improvement guidelines for diagnostic arteriography. Journal of Vascular and Interventional Radiology. 2014; 25 (12): 1873–1881. doi:10.1016/j.jvir.2014.07.020.; Гранов ДА, Поликарпов АА, Тилеубергенов ИИ и др. Случай успешной ретрансплантации печени у пациента с ранним тромбозом печеночной артерии, осложненным некрозом желчных протоков, сепсисом. Вестник трансплантологии и искусственных органов. 2019; 21 (3): 76–83. doi:10.15825/1995-1191-2019-3-76-83.; Aiolfi A, Inaba K, Strumwasser A et al. Splenic artery embolization versus splenectomy. Journal of Trauma and Acute Care Surgery. 2017; 83 (3): 356–360. doi:10.1097/ta.0000000000001550.; https://journal.transpl.ru/vtio/article/view/1232Test

الإتاحة: https://doi.org/10.15825/1995-1191-2020-3-99-106Test
https://doi.org/10.15825/1995-1191-2020-3Test
https://doi.org/10.1155/2014/961345Test
https://doi.org/10.1002/lt.21166Test
https://doi.org/10.1111/ajt.12034Test
https://doi.org/10.1016/j.jvs.2017.04.062Test
https://doi.org/10.1016/j.jvir.2014.07.020Test
https://doi.org/10.15825/1995-1191-2019-3-76-83Test
https://doi.org/10.1097/ta.0000000000001550Test
https://journal.transpl.ru/vtio/article/view/1232Test

المؤلفون: D. A. Granov, A. A. Polikarpov, I. I. Tileubergenov, V. N. Zhuikov, A. V. Moiseenko, A. R. Sheraliev, I. G. Kardanova, Д. А. Гранов, А. А. Поликарпов, И. И. Тилеубергенов, В. Н. Жуйков, А. В. Моисеенко, А. Р. Шералиев, И. Г. Карданова

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 21, № 3 (2019); 76-83 ; Вестник трансплантологии и искусственных органов; Том 21, № 3 (2019); 76-83 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2019-3

مصطلحات موضوعية: синдром обкрадывания селезеночной артерией, hepatic artery (HA) thrombosis, stent placement of HA, bile ducts necrosis, sepsis, hepatic abscesses, splenic artery steal syndrome, тромбоз печеночной артерии (ПА), стентирование ПА, некроз желчных протоков, сепсис, абсцессы печени

وصف الملف: application/pdf

العلاقة: https://journal.transpl.ru/vtio/article/view/1066/825Test; https://journal.transpl.ru/vtio/article/view/1066/846Test; Koji Umeshita, Yukihiro Inomata, Hiroyuki Furukawa, Mureo Kasahara, Seiji Kawasaki, Eiji Kobayashi, Norihiro Kokudo, Shotaro Sakisaka, Mitsuo Shimada. Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society. Hepatology research. Nov 2016; 46 (Issue 12): 1171–1186.; Adam R, Karam V, Delvart V, O’Grady J, Mirza D, Klempnauer J et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). Journal of hepatology. Sep 2012; 57 (Issue 3): 675–688.; Zarrinpar A, Hong JC. What is the prognosis after retransplantation of the liver? Adv Surg. 2012; 46: 87.; Pfitzmann R, Benscheidt B, Langrehr JM, Schumacher G, Neuhaus R, Neuhaus P. Trends and experiences in liver retransplantation over 15 years. Liver Transplantation. 2007; 13: 248.; Azoulay D, Linhares MM, Huguet E, Delvart V, Castaing D, Adam R et al. Decision for retransplantation of the liver. An experience and cost based analysis. Ann Surg. 2002; 236: 713.; Remiszewski P, Kalinowski P, Dudek K, Grodzicki M, Paluszkiewicz R, Zieniewicz K et al. Influence of selected factors on survival after liver retransplantation. Transplant Proc; 2011; 43: 3025.; Pareja E, Cortes M, Navarro R, Sanjuan F, López R, Mir J. Vascular Complications After Orthotopic Liver Transplantation: Hepatic Artery Thrombosis. Transplantation Proceedings. Oct 2010; 42 (Issue 8): 2970–2972.; Ashish Singhal, Kenneth Stokes, Anthony Sebastian, Harlan I Wright, Vivek Kohli. Endovascular treatment of hepatic artery thrombosis following liver transplantation. Transplant International. Mar 2010; 23 (Issue 3): 245–256.; Scarincia A, Sainz-Barrigaa M, Berrevoeta F, van den Bossche B, Colle I, Geerts A et al. Early Arterial Revascularization After Hepatic Artery Thrombosis May Avoid Graft Loss and Improve Outcomes in Adult Liver Transplantation. Transplantation Proceedings. Dec 2010; 42 (Issue 10): 4403–4408.; Готье СВ, Мойсюк ЯГ, Попцов ВН, Корнилов МН, Цирульникова ОМ, Ярошенко ЕБ и др. Опыт 100 трансплантаций трупной печени в одном центре. Вестник трансплантологии и искусственных органов. 2012; 14 (1): 6–14. Gautier SV, Moysyuk YaG, Poptsov VN, Kornilov MN, Tsirulnikova OM, Yaroshenko EB et al. One hundred deceased donor liver transplantations at a single center. Russian Journal of Transplantology and Artificial Organs. 2012; 14 (1): 6–14. [In Russ, English abstract].; Morell CM, Fabris L, Strazzabosco M. Vascular biology of the biliary epithelium. J Gastroenterol Hepatol. 2013; 28 (1): 26.; Kawecki D, Chmura A, Pacholczyk M, Lagiewska B, Adadynski L, Wasiak D et al. Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility. Med Sci Monit. 2009; 15 (12): CR628–CR637.; Wong T, Devlin J, Rolando N, Heaton N, Williams R. Clinical characteristics affecting the outcome of liver retransplantation. Transplantation. Sep 27th, 1997; 64 (Issue 6): 878–882.; Гранов АМ, Гранов ДА, Поликарпов АА, Таразов ПГ, Жеребцов ФК, Боровик ВВ и др. Методики интервенционной радиологии в пред- и послеоперационном периоде ортотопической трансплантации печени. Вестник трансплантологии и искуственных органов. 2016; 18: 97. Granov AM, Granov DA, Polikarpov AA, Tarazov PG, Zherebtsov FK, Borovik VV i dr. Metodiki interventsionnoy radiologii v pred- i posleoperatsionnom periode ortotopicheskoy transplantatsii pecheni. Vestnik transplantologii i iskustvennykh organov. 2016; 18: 97.; Masior L, Grąt M, Krasnodębski M, Patkowski W, Figiel W, Bik E, Krawczyk M. Prognostic Factors and Outcomes of Patients After Liver Retransplantation. June 2016; 48 (Issue 5): 1717–1720.; Kurz P, Kohler H, Meuer S, Hütteroth T, Meyer zum Büschenfelde K et al. Impaired cellular immune responses in chronic renal failure: evidence for a T cell deficit. Kidney Int. 1986; 29: 1209.; Roughneen PT, Gouma DJ, Kulkarni AD, Fanslow WF, Rowlands B. Impaired specific cell-mediated immunity in experimental biliary obstruction and its reversibility by internal biliary drainage. J Surg Res. 1986; 41: 113.; Clements WD, Halliday MI, McCaigue MD, Barclay RG, Rowlands BJ. Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg. 1993; 128: 200.; https://journal.transpl.ru/vtio/article/view/1066Test

الإتاحة: https://doi.org/10.15825/1995-1191-2019-3-76-83Test
https://doi.org/10.15825/1995-1191-2019-3Test
https://journal.transpl.ru/vtio/article/view/1066Test

المؤلفون: D. A. Granov, P. G. Tarazov, A. A. Polikarpov, V. V. Borovik, I. O. Rutkin, I. I. Tileubergenov, Д. А. Гранов, П. Г. Таразов, А. А. Поликарпов, В. В. Боровик, И. О. Руткин, И. И. Тилеубергенов

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 18, № 1 (2016); 17-21 ; Вестник трансплантологии и искусственных органов; Том 18, № 1 (2016); 17-21 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2016-1

مصطلحات موضوعية: синдром гиперспленизма, embolization of the splenic artery, splenic artery steal syndrome, syndrome of hypersplenism, эмболизация селезеночной артерии, синдром обкрадывания селезеночной артерией

وصف الملف: application/pdf

العلاقة: https://journal.transpl.ru/vtio/article/view/614/522Test; Altaca G, Scigliano E, Guy SR, Sheiner P A, Reich DJ, Schwartz ME et al. Persistent hypersplenism early after liver transplant: the role of splenectomy. Transplantation. 1997 Nov; 64 (10): 1481–1483.; Neumann UP, Langrehr JM, Kaisers U, Lang M, Schmitz V, Neuhaus P. Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation. Transplant International. 2002 May; 15 (5): 226–232.; Lüsebrink R, Blumhardt G, Lohmann R, Bachmann S, Knoop M, Lemmens HP. Does concommitant splenectomy raise the mortality of liver transplant recipients? Transplant International. 1994 Dec; 7 (S1): 634–636.; Palsson B, Hallen M, Forsberg AM, Alwmark A. Partial splenic embolization: long-term outcome. Langenbecks Arch Surg. 2003 Feb; 387 (11–12): 421–426.; Alvarez D, Gerona S, Waisburg Z, Ciardullo M, de Santibanes E, Mastai R. Splanchnic hyperemia after liver transplantation in patients with end-stage liver disease. Liver Transpl Surg. 1998; 4: 300–303.; Руткин ИО, Таразов ПГ, Гранов ДА, Осовских ВВ, Генералов МИ, Жеребцов ФК и др. Возможности эмболизации селезеночной артерии в лечении «синдрома обкрадывания» после ортотопической трансплантации печени. Трансплантология. 2010 Май; 1: 26–30. Rutkin IO, Tarazov PG, Granov DA, Osovskikh VV, Generalov MI, Zherebtsov FK et al. Capabilities of splenic artery embolization in the treatment of steal syndrome after orthotopic liver transplantation. Transplantologia. 2010 May; 1: 26–30.; N’Kontchou G, Seror O, Bourcier V et al. Partial splenic embolization in patients with cirrhosis: effi cacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005 Feb; 17 (2): 179–184.; Murata K, Shiraki K, Takase K et al. Long term followup for patients with liver cirrhosis after partial splenic embolization. Hepatogastroenterology. 1996 Sep-Oct; 43 (11): 1212–1217.; Ohmoto K, Iguchi Y, Miyake I et al. Long-term evaluation of partial splenic embolization for liver cirrhosis and hepatocellular carcinoma accompanied by hypersplenism. Hepatology Research. 1998 Jun; 11 (2): 73–83.; Herrero JI, Sangro B, Quiroga J et al. Partial splenic embolization in the treatment of thrombocytopenia after liver transplantation. Transplantation. 1997 Feb; 63 (3): 482–484.; Sockrider CS, Boykin KN, Green J et al. Partial splenic embolization for hypersplenism before and after liver transplantation. Clin Transplant. 2002; 16 (7): 59–61.; Sakai T, Shiraki K, Inoue H et al. Complications of partial splenic embolization in cirrhotic patients. Dig Dis Sci. 2002 Feb; 47 (2): 388–391.; https://journal.transpl.ru/vtio/article/view/614Test

الإتاحة: https://doi.org/10.15825/1995-1191-2016-1-17-21Test
https://doi.org/10.15825/1995-1191-2016-1Test
https://journal.transpl.ru/vtio/article/view/614Test

المؤلفون: A. M. Granov, D. A. Granov, F. K. Zherebtsov, V. V. Osovskih, D. N. Maystrenko, P. K. Tarazov, V. V. Borovik, I. O. Rutkin, O. A. Gerasimova, S. P. Tsurupa, I. I. Tileubergenov, A. A. Polikarpov, S. V. Shapoval, A. I. Urbanskij, A. D. Belov, T. G. Mihaylichenko, А. М. Гранов, Д. А. Гранов, Ф. К. Жеребцов, В. В. Осовских, Д. Н. Майстренко, П. К. Таразов, В. В. Боровик, И. О. Руткин, О. А. Герасимова, С. П. Цурупа, И. И. Тилеубергенов, А. А. Поликарпов, С. В. Шаповал, А. И. Урбанский, А. Д. Белов, Т. Г. Михайличенко

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 17, № 2 (2015); 96-99 ; Вестник трансплантологии и искусственных органов; Том 17, № 2 (2015); 96-99 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2015-2

وصف الملف: application/pdf

العلاقة: https://journal.transpl.ru/vtio/article/view/525/456Test; https://journal.transpl.ru/vtio/article/view/525Test

الإتاحة: https://doi.org/10.15825/1995-1191-2015-2-96-99Test
https://doi.org/10.15825/1995-1191-2015-2Test
https://journal.transpl.ru/vtio/article/view/525Test